Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.

MLA

Romero-Lorca, Alicia, et al. “Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.” PloS One, vol. 10, no. 7, July 2015, p. e0132269. EBSCOhost, https://doi.org/10.1371/journal.pone.0132269.

APA

Romero-Lorca, A., Novillo, A., Gaibar, M., Bandrés, F., & Fernández-Santander, A. (2015). Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients. PloS One, 10(7), e0132269. https://doi.org/10.1371/journal.pone.0132269

Chicago

Romero-Lorca, Alicia, Apolonia Novillo, María Gaibar, Fernando Bandrés, and Ana Fernández-Santander. 2015. “Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.” PloS One 10 (7): e0132269. doi:10.1371/journal.pone.0132269.